(Q72233865)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

1 reference

L A Christensen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

J Fallingborg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

B A Jacobsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

K Abildgaard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

H H Rasmussen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S N Rasmussen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S H Hansen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 October 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

1831-1836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

Disposition of 5-aminosalicylic acid from 5-aminosalicylic acid-delivering drugs during accelerated intestinal transit in healthy volunteers

25 October 2019

cites work

1 reference

12 December 2020

Kinetics of 5-aminosalicylic acid after jejunal instillation in man.

1 reference

12 December 2020

Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.

1 reference

12 December 2020

Nephrotoxic lesions from 5-aminosalicylic Acid.

1 reference

12 December 2020

Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis

1 reference

12 December 2020

The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis

1 reference

12 December 2020

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse

1 reference

12 December 2020

Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract

1 reference

12 December 2020

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans

1 reference

12 December 2020

Oral 5-aminosalicyclic acid in children with colonic chronic inflammatory bowel disease: clinical and pharmacokinetic experience.

1 reference

12 December 2020

A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics

1 reference

12 December 2020

Nephrotic syndrome after treatment with 5-aminosalicylic acid

1 reference

12 December 2020

Simple and rapid method for the simultaneous determination of the eight main metabolites and conjugates of sulphasalazine in human plasma, urine and faeces using dynamically modified silica

1 reference

12 December 2020

Release of 5-aminosalicylic acid from Pentasa during normal and accelerated intestinal transit time

1 reference

12 December 2020

A controlled study of faecal distribution in ulcerative colitis and proctitis

1 reference

12 December 2020

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds

1 reference

12 December 2020

Studies on the mechanism of bowel disturbance in ulcerative colitis.

1 reference

12 December 2020

[Nephritis from 5-aminosalicylic acid]

1 reference

12 December 2020

Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis

1 reference

12 December 2020

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid

1 reference

12 December 2020

Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man.

1 reference

12 December 2020

Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01296106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8104772%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference